Clinical course and management of paclitaxel extravasation

  • Authors:
    • A Du Bois
    • M Fehr
    • H Bochtler
    • O Koechli
  • View Affiliations

  • Published online on: September 1, 1996     https://doi.org/10.3892/or.3.5.973
  • Pages: 973-974
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Four case reports describing our experience with clinical course and management of paclitaxel extravasation are presented. Local reactions included swelling, mild pain, erythema, induration and hyperpigmentation, but no ulceration. Two patients were treated with cooling only while two further patients received additional hyaluronidase injections subcutaneously. The latter patients suffered longer from symptoms. Local reaction resolved within two weeks and paclitaxel treatment was continued in 3 of 4 patients without further complications. Overall, paclitaxel extravasation induced only mild soft tissue reaction and cooling should be considered standard treatment.

Related Articles

Journal Cover

September 1996
Volume 3 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Du Bois A, Fehr M, Bochtler H and Koechli O: Clinical course and management of paclitaxel extravasation. Oncol Rep 3: 973-974, 1996
APA
Du Bois, A., Fehr, M., Bochtler, H., & Koechli, O. (1996). Clinical course and management of paclitaxel extravasation. Oncology Reports, 3, 973-974. https://doi.org/10.3892/or.3.5.973
MLA
Du Bois, A., Fehr, M., Bochtler, H., Koechli, O."Clinical course and management of paclitaxel extravasation". Oncology Reports 3.5 (1996): 973-974.
Chicago
Du Bois, A., Fehr, M., Bochtler, H., Koechli, O."Clinical course and management of paclitaxel extravasation". Oncology Reports 3, no. 5 (1996): 973-974. https://doi.org/10.3892/or.3.5.973